Strategic interactions in multi-institutional epidemics of antibiotic resistance
- 26 January 2005
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (8) , 3153-3158
- https://doi.org/10.1073/pnas.0409523102
Abstract
The increasing frequency of antibiotic resistance in hospital-acquired infections is a major public health concern that has both biological and economic causes. Here we develop conceptual mathematical models that couple the economic incentives and population biology of hospital infection control (HIC). We show that the optimal investment by a hospital for HIC changes with the proportion of patients already colonized with antibiotic-resistant bacteria (ARB) at the time of admission. As that proportion increases, the optimal behavior of a hospital is to increase spending to control ARB with low transmissibility and decrease spending on those with high transmissibility. In some cases, the global optimum investment in HIC can shift discontinuously from one that contains transmission to a do-nothing policy once the proportion already colonized at the time of admission becomes too great. We also show that investments in HIC are determined by a strategic game when several hospitals share patients. Hospitals acting selfishly and rationally will free-ride on the investments of other hospitals, and the level of free-riding should increase with the number of other hospitals in the area. Thus, in areas with many hospitals, the rational strategy for each hospital is to spend less than in areas with few hospitals. Thus, we predict that transmission rates and the prevalence of ARB should be higher in urban hospitals, for instance, compared with rural hospitals. We conclude that regional coordination and planning for HIC is an essential element of public health planning for hospital-acquired infections.Keywords
This publication has 32 references indexed in Scilit:
- Agricultural Antibiotics and Human HealthPLoS Medicine, 2005
- Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteriaProceedings of the National Academy of Sciences, 2002
- What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals?BMJ, 2002
- Vancomycin-resistant enterococci: why are they here, and where do they come from?The Lancet Infectious Diseases, 2001
- National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, Issued August 2001American Journal of Infection Control, 2001
- Effect of Abolishment of the Use of Antimicrobial Agents for Growth Promotion on Occurrence of Antimicrobial Resistance in Fecal Enterococci from Food Animals in DenmarkAntimicrobial Agents and Chemotherapy, 2001
- Control of Vancomycin-Resistant Enterococcus in Health Care Facilities in a RegionNew England Journal of Medicine, 2001
- Colonization of Skilled‐Care Facility Residents with Antimicrobial‐Resistant PathogensJournal of the American Geriatrics Society, 2001
- Evaluation of a successful vancomycin-resistant Enterococcus prevention intervention in a community of health care facilitiesAmerican Journal of Infection Control, 2001
- The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptionsProceedings of the National Academy of Sciences, 2000